Philips ACT(s)@Scale with three-year research study (UK/EU)

Philips is expanding their just-concluded three-year ACT program with ACT@Scale, a three-year research study which will track up to 75,000 chronic disease patients on health outcomes and economic impact data. They are working with specific EU regions (Northern Ireland, Spain’s Catalonia and Basque Country, southern Denmark and northern Netherlands) which are already innovating care/coordination services and use of technology in specific areas. A major university consortium is also joining with Philips to conduct the study: University Medical Center Groningen (The Netherlands), Aristotle University of Thessaloniki (Greece), City University London (UK), Universitätsklinikum Würzburg/Klinikum der Bayerischen Julius-Maximilians-Universität (Germany), University of Hull (UK), Kronikgune-Centre for Research Excellence in Chronicity (Basque Country, Spain) and Hospital Clinic of Barcelona (Spain). ACT@Scale is part of the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA), an initiative from the European Commission under its Innovation Union strategy that aims to increase the average healthy lifespan by two years by 2020. More will be presented at eHealth Week, 8-10 June, Beurs van Berlage, Amsterdam, The Netherlands. Philips release.